RXI PHARMACEUTICALS CORP NEW's ticker is RXIIW and the CUSIP is 74979C113. A total of 4 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $288,000 | -23.2% | 2,216,855 | -0.2% | 0.00% | – |
| Q3 2017 | $375,000 | -6.2% | 2,220,255 | -0.1% | 0.00% | – |
| Q2 2017 | $400,000 | -18.2% | 2,222,222 | 0.0% | 0.00% | – |
| Q1 2017 | $489,000 | +10.1% | 2,222,222 | 0.0% | 0.00% | – |
| Q4 2016 | $444,000 | – | 2,222,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,238,487 | $492,000 | 0.03% |
| Hudson Bay Capital Management LP | 781,317 | $172,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,222,222 | $489,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 30,000 | $7,000 | 0.00% |